^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
EVI1 (MECOM) Breakapart Fish Probe Kit

Company:
Sysmex Corp
Type:
FDA Approved
Related tests:

Details

Evidence
News
The EVI1 (MECOM) Breakapart FISH Probe Kit is a fluorescence in situ hybridization (FISH) Test used to detect rearrangement involving the EVI1 (MECOM) region on chromosome 3 at location 3q26.2, in fixed bone marrow specimens from patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The test is indicated for characterization of patient specimens consistent with World Health Organization (WHO) guidelines for Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition) and in conjunction with other clinicopathological criteria. The assay results are intended to be interpreted by a qualified pathologist or cytogeneticist. The test is not intended for use as a stand-alone diagnostic, disease screening, or as a companion diagnostic.
Cancer:
Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Gene:
MECOM (MDS1 And EVI1 Complex Locus)
Method:
Fluorescence in situ hybridization (FISH)
Approvals
Date
Cancer
Gene
Drug
By
12/21/18
FDA